Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03859310 · ClinicalTrials.gov registry record
Precision of OCT and OCTA-based Ocular Measurements
A clinical trial, sponsored by Optovue.
- Completed
- Registry status
- 144
- Enrollment target
NCT03859310: Completed study, sponsored by Optovue.
NCT03859310 is a clinical trial that has completed, run by Optovue. The registered enrollment target is 144 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03859310 has completed, sponsored by Optovue.
- COMPLETED
- Registry status
- 144 participants
- Enrollment target
Study Summary
Precision of OCT- and OCTA-based Ocular Measurements
Primary Outcome
calculated value minus the measured value
Interventions
- DEVICE SD-OCT
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 144 participants |
| Start Date | 2019-01-29 |
| Est. Completion | 2019-08-30 |
What the finished NCT03859310 record still lists
NCT03859310 is an observational study that tracks outcomes without assigning an intervention. The registered 144 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which SD-OCT is the first listed.
NCT03859310 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03859310 about?
NCT03859310 is a clinical study titled "Precision of OCT and OCTA-based Ocular Measurements". Precision of OCT- and OCTA-based Ocular Measurements
What is the current status of trial NCT03859310?
This trial is currently completed. The enrollment target is 144 participants. The study started on 2019-01-29. Estimated completion is 2019-08-30.
What interventions are being tested in trial NCT03859310?
The interventions under investigation include: SD-OCT (DEVICE).
Who is sponsoring clinical trial NCT03859310?
This trial is sponsored by Optovue, which has 12 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01861106 · 144 participants · Phase 2
Allogeneic Hematopoietic Stem Cell Transplant for GATA2 Mutations
- NCT03482245 · 144 participants · NA
The Role of Circadian Clock Proteins in Innate and Adaptive Immunity
- NCT03504683 · 144 participants · NA
MEAL TIMING Study: Effect of Time-Restricted Feeding on 24-hour Glycemic Control, Blood Pressure, and Cardiovascular Disease Risk Factors in Adults With Prediabetes
- NCT03905603 · 144 participants · Early Phase 1
Relative Contributions of Predictors of Hyperandrogenism in Older vs. Young Women With PCOS
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI